Fig. 3.

Components of the total estimated costs of the national programmes for the prevention of mother-to-child transmission (PMTCT) of HIV, Namibia and Rwanda, 2009

ART, antiretroviral therapy;^a ARV, antiretroviral; HIV, human immunodeficiency virus; SXT, co-trimoxazole.

^a As early as week 28 of gestation to 12 months postpartum;¹⁵

Note: Proportions are shown for both the minimum and maximum estimated total costs for each country.